论文信息 - Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development. - 字舞流文

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Zhiwei Wang | X. Liu | L. Luo | Changyou Zhou | Lai Wang | D. Su | Wenfeng Gong | R.‐Y. Qi | Yiyuan Wu | Beibei Jiang | Yin Guo | Lei Lv | Chang‐xin Huo | Ye Liu | Fan Wang | M. Qiu | Fenglong Yu | Hexiang Wang | Bo-Xue Ren | Yutong Zhu | Xing Wang | Yuan Zhao | Yajuan Gao | Min Wei | Yingcai Feng | Hong Xu | Xuebing Sun | Yong Liu | T. Tang | Xianzhao Kuang | Hao Peng | H. Yan | Dexu Xu | Zhen Qin